Stock Watch: CEO’s Bullish Projection Helps GSK Outshine Merck

But Both Suffer Lower US Vaccines Sales

 
• By Andy Smith
  
Stock Watch Image, Andy Smith
ANDY SMITH OFFERS A LIFE SCIENCE INVESTOR'S PERSPECTIVE ON BIOPHARMA BUSINESS

More from Stock Watch

More from Scrip